Myxedema Coma Leading to Acute Coronary Syndrome: A Case Report

Myxedema coma is a rare and life-threatening medical condition. We present a case of poorly controlled hypothyroidism that initially caused myxedema coma and then led to acute coronary syndrome (ACS). A 57-year-old woman with a history of Hashimoto's thyroiditis and coronary artery bypass grafting (CABG) came in with fatigue and worsening left-sided chest pain that occurred even at rest for the past 12 hours. She has not been taking her levothyroxine as prescribed and has not been seeing her endocrinologist for follow-up. When she arrived, her vitals showed that she had a heart rate of 53 beats per minute (sinus bradycardia), but otherwise, she was stable. The laboratory tests showed elevated levels of high sensitivity troponin T at 42 ng/L (normal value: <14 ng/L), a thyroid stimulating hormone level of 408 mIU/L (normal value: 0.5-2.5 mIU/L), a free thyroxine level of 0.4 (normal range: 0.8-1.8 ng/mL), and a decreased glomerular filtration rate of 71 mL/min/1.73 m<sup>2</sup> (normal range: 90-120 mL/min/1.73 m<sup>2</sup>). Although the electrocardiogram did not show ST-T wave changes, the thrombolysis in myocardial infarction (TIMI) risk score was five. Additionally, there was a new onset decrease in ejection fraction to 40% and mild hypokinesia of the left ventricle on the echocardiogram. She was started on a heparin drip in the emergency department and subsequently underwent cardiac catheterization with drug-eluting stent (DES) placement. Myxedema coma score was 40 suggestive of coma risk myxedema and eventually, she was admitted to the intensive care unit. Her condition was managed using intravenous levothyroxine, liothyronine, and hydrocortisone. After her symptoms subsided, she was discharged with a prescription for dual antiplatelet agents and levothyroxine. Due to its rarity and high mortality rate, it is crucial for physicians to maintain a high level of suspicion for myxedema coma and promptly initiate treatment. This is especially important when a patient with a history of hypothyroidism presents with cardiac issues such as ACS or bradycardia that do not entirely align with the clinical picture.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-05-18
DOI
https://doi.org/10.7759/cureus.84324
Citations
1
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myxedema Coma Leading to Acute Coronary Syndrome: A Case Report

Aishwarya Yamparala, Warren Fernandes, Amir Joshi, Richard Wholey et al.
1 citations
Cureus
Thyroid Disorders and Treatments
1.29
article

Myxedema Coma Leading to Acute Coronary Syndrome: A Case Report

Aishwarya Yamparala, Warren Fernandes, Amir Joshi, Richard Wholey, Saroj Kumar Jha, Adit M Patel, Nitish Sharma
article en
1 citations

Abstract

Myxedema coma is a rare and life-threatening medical condition. We present a case of poorly controlled hypothyroidism that initially caused myxedema coma and then led to acute coronary syndrome (ACS). A 57-year-old woman with a history of Hashimoto's thyroiditis and coronary artery bypass grafting (CABG) came in with fatigue and worsening left-sided chest pain that occurred even at rest for the past 12 hours. She has not been taking her levothyroxine as prescribed and has not been seeing her endocrinologist for follow-up. When she arrived, her vitals showed that she had a heart rate of 53 beats per minute (sinus bradycardia), but otherwise, she was stable. The laboratory tests showed elevated levels of high sensitivity troponin T at 42 ng/L (normal value: <14 ng/L), a thyroid stimulating hormone level of 408 mIU/L (normal value: 0.5-2.5 mIU/L), a free thyroxine level of 0.4 (normal range: 0.8-1.8 ng/mL), and a decreased glomerular filtration rate of 71 mL/min/1.73 m<sup>2</sup> (normal range: 90-120 mL/min/1.73 m<sup>2</sup>). Although the electrocardiogram did not show ST-T wave changes, the thrombolysis in myocardial infarction (TIMI) risk score was five. Additionally, there was a new onset decrease in ejection fraction to 40% and mild hypokinesia of the left ventricle on the echocardiogram. She was started on a heparin drip in the emergency department and subsequently underwent cardiac catheterization with drug-eluting stent (DES) placement. Myxedema coma score was 40 suggestive of coma risk myxedema and eventually, she was admitted to the intensive care unit. Her condition was managed using intravenous levothyroxine, liothyronine, and hydrocortisone. After her symptoms subsided, she was discharged with a prescription for dual antiplatelet agents and levothyroxine. Due to its rarity and high mortality rate, it is crucial for physicians to maintain a high level of suspicion for myxedema coma and promptly initiate treatment. This is especially important when a patient with a history of hypothyroidism presents with cardiac issues such as ACS or bradycardia that do not entirely align with the clinical picture.

CureusVol. 17(5)
University of Massachusetts Chan Medical School (US), Saint Vincent Hospital (US), Tribhuvan University Teaching Hospital (NP)
Good health and well-being
Openalex Percentile: Top 19%
Thyroid Disorders and Treatments
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.